Sep 10, 2024 07:01AM
Sep 10, 2024 07:00AM
Sep 10, 2024 06:44AM
Aug 14, 2024 07:00AM
Jun 21, 2024 08:00AM
May 31, 2024 08:02AM
May 31, 2024 08:00AM Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections
May 13, 2024 07:04AM
May 13, 2024 07:00AM
Mar 28, 2024 07:00AM
Mar 6, 2024 08:00AM
Mar 6, 2024 08:00AM
Jul 26, 2021 12:20PM
Jul 2, 2021 09:29AM Pre-Open Movers 07/02: (ALEC) (OSG) (SPCE) Higher; (ITRM) (DIDI) (BSGM) Lower (more...)
Jul 2, 2021 06:17AM
Jul 1, 2021 06:30PM
Jul 1, 2021 06:30PM
May 28, 2021 09:25AM
May 27, 2021 05:45PM
May 27, 2021 05:01PM
May 27, 2021 05:00PM Iterum Therapeutics Provides Update on NDA Review
May 27, 2021 05:00PM
May 14, 2021 07:00AM
May 14, 2021 07:00AM
Apr 6, 2021 08:30AM
Apr 6, 2021 08:30AM
Mar 16, 2021 07:33AM
Mar 16, 2021 07:30AM Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors
Mar 16, 2021 07:30AM
Mar 15, 2021 06:21AM
Mar 12, 2021 07:00AM
Mar 12, 2021 07:00AM
Feb 10, 2021 06:40PM
Feb 10, 2021 06:40PM
Feb 3, 2021 11:34PM Iterum Therapeutics plc Increases Previously Announced Bought Deal Public Offering of Ordinary Shares to $40.0 Million
Feb 3, 2021 11:34PM
Feb 3, 2021 05:51PM
Feb 3, 2021 05:51PM
Feb 1, 2021 07:00AM
Feb 1, 2021 07:00AM
Jan 25, 2021 07:02AM
Jan 25, 2021 07:00AM Iterum Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Oral Sulopenem
Jan 25, 2021 07:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All